J B Chemicals & Pharmaceuticals Reports Strong Financial Results Amid Sector Growth in June 2025
J B Chemicals & Pharmaceuticals has announced its financial results for the quarter ending June 2025, highlighting a record operating cash flow of Rs 902.45 crore and a peak dividend payout ratio of 36.58%. Net sales reached Rs 1,093.94 crore, while operating profit and profit before tax also showed positive trends.
J B Chemicals & Pharmaceuticals has reported its financial results for the quarter ending June 2025, showcasing a notable performance within the pharmaceuticals and biotechnology sector. The company has experienced a significant adjustment in its evaluation, with its score reflecting a shift from -1 to 16 over the past three months.Key highlights from the financial results indicate that J B Chemicals & has achieved its highest operating cash flow at Rs 902.45 crore, demonstrating consistent growth over the last three years. The dividend payout ratio has also reached a peak of 36.58%, indicating a commitment to returning profits to shareholders. Additionally, net sales for the quarter stood at Rs 1,093.94 crore, marking the highest figure in the last five quarters, while operating profit and profit before tax have also shown positive trends, reaching Rs 300.87 crore and Rs 257.06 crore, respectively.
However, the company has reported an increase in non-operating income, which, while at its highest in recent quarters, may not be a sustainable source of revenue. Overall, J B Chemicals & Pharmaceuticals continues to navigate its financial landscape with a focus on operational performance and shareholder returns.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
